Roche Diagnostics International Ltd-医療機器分野:企業M&A・提携分析

◆英語タイトル:Roche Diagnostics International Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010929
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Roche Diagnostics International Ltd (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devices; analyzers, blood glucose meters; laboratory information, workflow and data management software; and instruments and reagents for life science research. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. It has operations in the Americas, Asia Pacific, Africa, the Middle East and Europe. Roche Diagnostics manages all the central functions of the Diagnostics business of F. Hoffmann-La Roche Ltd and is headquartered in Rotkreuz, Switzerland.

Roche Diagnostics International Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Roche Diagnostics International Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Roche Diagnostics International Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Roche Diagnostics International Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Roche Diagnostics International Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Roche Diagnostics International Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Roche Diagnostics International Ltd, Medical Equipment, Deal Details 11
Asset Purchase 11
Roche Diagnostics to Acquire Tissue Dissection Technology from AvanSci Bio 11
Partnerships 12
Cellnovo Enters into Agreement with Roche Diagnostics 12
Molecular Devices Enters into Co-Development Agreement with Roche Diagnostics 13
Advanced Biological Labs Extends Co-Promotion Agreement with Roche Diagnostics 14
AUT University Forms Joint Venture with Roche Diagnostics 15
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 16
Advanced Biological Labs And Roche Diagnostics Enter Into Agreement To Promote Sequencing, Genotyping And Drug Resistance Products 17
Genia Technologies Enters Into Co-Development Agreement With Columbia University And Harvard University 18
Sysmex Extends Distribution Agreement With Roche 19
Acquisition 20
Roche Diagnostics Acquires Genia for up to USD350 Million 20
Roche Completes Acquisition Of PVT Probenverteiltechnik And PVT Lab Systems For US$126.14 Million 21
Roche Diagnostics International Ltd – Key Competitors 22
Roche Diagnostics International Ltd – Key Employees 23
Roche Diagnostics International Ltd – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 25
Recent Developments 26
Product News 26
Dec 08, 2017: Oncolytic Adenovirus Expressing BiTE Effectively Recruits T Cells to Kill Diverse Cancer Cell Types 26
03/23/2016: Roche Submits Filing To FDA For Cobas Procalcitonin Assay To Help Clinicians Assess Response Of Septic Patients To Treatment 27
03/21/2016: FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis 28
03/10/2016: Roche receives approval in Japan for the cobas EGFR Mutation Test v2 29
03/08/2016: Roche receives China Food and Drug Administration approval for the CINtec PLUS Cytology test to help prevent women from developing cervical cancer 30
03/02/2016: Roche submits filing to FDA for HbA1c testing solution to help meet increasing demand for HbA1c testing of people with diabetes 31
02/10/2016: NICE Recommends Further Research To Be Carried Out On The LightCycler SeptiFast Test MGRADE 32
01/13/2016: One-hour diagnosis of heart attack possible with troponin T test from Roche 33
01/07/2016: New Study Shows How Pregnant Women Can Rule Out Pre-eclampsia With One Simple Blood Test 34
Product Approvals 36
Mar 21, 2016: FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis 36
Mar 10, 2016: Roche receives approval in Japan for the cobas EGFR Mutation Test v2 37
Mar 08, 2016: Roche receives China Food and Drug Administration approval for the CINtec PLUS Cytology test to help prevent women from developing cervical cancer 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Roche Diagnostics International Ltd, Medical Equipment, Key Facts, 2016 2
Roche Diagnostics International Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Roche Diagnostics International Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Roche Diagnostics International Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Roche Diagnostics International Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Roche Diagnostics International Ltd, Deals By Market, 2011 to YTD 2017 9
Roche Diagnostics International Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Roche Diagnostics to Acquire Tissue Dissection Technology from AvanSci Bio 11
Cellnovo Enters into Agreement with Roche Diagnostics 12
Molecular Devices Enters into Co-Development Agreement with Roche Diagnostics 13
Advanced Biological Labs Extends Co-Promotion Agreement with Roche Diagnostics 14
AUT University Forms Joint Venture with Roche Diagnostics 15
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 16
Advanced Biological Labs And Roche Diagnostics Enter Into Agreement To Promote Sequencing, Genotyping And Drug Resistance Products 17
Genia Technologies Enters Into Co-Development Agreement With Columbia University And Harvard University 18
Sysmex Extends Distribution Agreement With Roche 19
Roche Diagnostics Acquires Genia for up to USD350 Million 20
Roche Completes Acquisition Of PVT Probenverteiltechnik And PVT Lab Systems For US$126.14 Million 21
Roche Diagnostics International Ltd, Key Competitors 22
Roche Diagnostics International Ltd, Key Employees 23
Roche Diagnostics International Ltd, Other Locations 24
Roche Diagnostics International Ltd, Subsidiaries 24
Roche Diagnostics International Ltd, Joint Venture 25

★海外企業調査レポート[Roche Diagnostics International Ltd-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UGI Corp (UGI):企業の財務・戦略的SWOT分析
    UGI Corp (UGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Green Plains Inc (GPRE):企業の財務・戦略的SWOT分析
    Green Plains Inc (GPRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Packaging Corporation of America:企業の戦略・SWOT・財務分析
    Packaging Corporation of America - Strategy, SWOT and Corporate Finance Report Summary Packaging Corporation of America - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • OraSolv AB (OS):企業の財務・戦略的SWOT分析
    OraSolv AB (OS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Metropolitan Bank and Trust Company:企業の戦略・SWOT・財務情報
    Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report Summary Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Corgenix Medical Corp-医療機器分野:企業M&A・提携分析
    Summary Corgenix Medical Corp (Corgenix), a subsidiary of Orgentec Diagnostika GmbH is a medical device company that offers medical diagnostic solutions. The company offers vascular disease products, infectious disease products, non-invasive liver biomarkers, and instrumentation. It offers an instru …
  • Attunity Ltd (ATTU):企業の財務・戦略的SWOT分析
    Summary Attunity Ltd (Attunity) is a technology company that provides data management software, cloud database replication solutions, and google cloud database tools. The company provides data management software solutions that enable access, sharing, management, and distribution of data. It offers …
  • bioMerieux Inc-医療機器分野:企業M&A・提携分析
    Summary bioMerieux Inc (bioMerieux), a subsidiary of Institut Merieux SA is a provider of diagnostic solutions. The company offers its products for clinical solutions which include blood culture, cancer diagnostics, cardiovascular disease, cardiovascular pathology, clinical laboratories, companion d …
  • Butler National Corporation:企業の戦略・SWOT・財務情報
    Butler National Corporation - Strategy, SWOT and Corporate Finance Report Summary Butler National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • HUYA Bioscience International LLC-製薬・医療分野:企業M&A・提携分析
    Summary HUYA Bioscience International LLC (HUYA) is a developer of early and late stage drug candidates. The company’s pipeline products comprise HBI-8000, HBI-3000, and HBI-3802. Its HBI-8000 is a novel oral inhibitor of histone deacetylases; HBI-3000 is a channel blocker for the treatment of arrhy …
  • Walton Electric Membership Corporation:企業の発電所・SWOT分析2018
    Walton Electric Membership Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …
  • Icici Bank Ltd
    Icici Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Icici Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • algoWatt SpA (ALW):企業の財務・戦略的SWOT分析
    Summary algoWatt SpA (algoWatt), formerly TerniEnergia SpA, is an energy services provider. It designs, develops and integrates solutions for the management of energy and natural resources. The company’s product offerings include building energy management systems, control and maintenance systems, e …
  • Steelcase Inc (SCS):企業の財務・戦略的SWOT分析
    Steelcase Inc (SCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Beactica AB-製薬・医療分野:企業M&A・提携分析
    Summary Beactica AB (Beactica) is a drug discovery company that focuses on the development of novel therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis and antibody interaction …
  • Suncor Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Suncor Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Suncor Energy Inc. (Suncor) is an integrated energy company that mainly focuses on the development of Athabasca oil sands. It carries out development and up gradation of oil sands; offshore and ons …
  • Takara Holdings Inc (2531):企業の財務・戦略的SWOT分析
    Takara Holdings Inc (2531) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Big 5 Sporting Goods Corp:企業の戦略・SWOT・財務分析
    Big 5 Sporting Goods Corp - Strategy, SWOT and Corporate Finance Report Summary Big 5 Sporting Goods Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Total Brain Ltd (TTB):企業の財務・戦略的SWOT分析
    Summary Total Brain Ltd (TBL) formerly, Brain Resource Ltd is a healthcare service provider that offers therapies. The company carries out research and development of brain products. TBL’s products comprise iSPOT, Total Brain and MyBrainSolutions. The company’s Total Brain is a brain health solution …
  • Zafgen Inc (ZFGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Zafgen Inc (Zafgen) is a clinical-stage biopharmaceutical company that develops transformative therapies for patients affected by a range of metabolic diseases. Its pipeline product portfolio includes ZGN-1061, a small molecule MetAP2 inhibitor being developed for patients with type 2 diabet …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆